Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Income from Non-Controlling Interests: 2015-2024

Historic Income from Non-Controlling Interests for vTv Therapeutics (VTVT) over the last 10 years, with Dec 2024 value amounting to -$4.2 million.

  • vTv Therapeutics' Income from Non-Controlling Interests fell 55.82% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 11.49%. This contributed to the annual value of -$4.2 million for FY2024, which is 25.77% up from last year.
  • As of FY2024, vTv Therapeutics' Income from Non-Controlling Interests stood at -$4.2 million, which was up 25.77% from -$5.7 million recorded in FY2023.
  • Over the past 5 years, vTv Therapeutics' Income from Non-Controlling Interests peaked at -$4.2 million during FY2024, and registered a low of -$5.9 million during FY2022.
  • For the 3-year period, vTv Therapeutics' Income from Non-Controlling Interests averaged around -$5.3 million, with its median value being -$5.7 million (2023).
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first skyrocketed by 51.62% in 2020, then declined by 24.56% in 2022.
  • vTv Therapeutics' Income from Non-Controlling Interests (Yearly) stood at -$4.3 million in 2020, then dropped by 10.25% to -$4.7 million in 2021, then decreased by 24.56% to -$5.9 million in 2022, then climbed by 3.27% to -$5.7 million in 2023, then rose by 25.77% to -$4.2 million in 2024.